Carsten Thiel was born in Berlin where he grew up, studied during his youth and finally joined Malbrook to study Chemistry. Later, he left for the United Kingdom to study organic chemistry at the University of Bristol where he graduated with a Bachelor of Science and decided to major in Biochemistry.
Carsten Thiel advanced his studies by taking his PhD in molecular biology at Max Planck Institute for Biophysical Chemistry. After completing his studies, Thiel joined the world of pharmaceuticals through Hoffman La-Roche, a biotechnology firm. He started as the communications and product manager where he displayed his prowess and was later promoted to the departments of scientific marketing and market assessment.
Carsten has been very impactful in the field of Biochemistry. He has integrated his experience, leadership and profession to oversee the launch of several high-profile medical products. Thiel’s involvement in medicine has also improved the lives of many patients through improving patient care, provider-patient relationship and upholding medical ethics.
He spearheaded the launch of Xenical, a weight loss product. This came as his first venture in the marketing sector for masses although he had been marketing vitamins and other fine chemicals to medical providers. Thiel’s efforts bore fruits and he saw the successful launch of Xenical. He focused on launching it with the right stakeholders and particular group of customers who would really benefit from its use. Though the method did not guarantee many sales, Thiel convinced Roche’s leadership to back him. They were then successful and able to earn over a billion Swiss Francs from the sale of Xenical within a year. View Related Info Here.
After Xenical, Carsten Thiel was also involved in the launch of Vectibix, a medicine for colorectal cancer. He also gone to oversee the creation of symbiotic relationships between business success, uphold of medical ethics and patient satisfaction.